ITCCIR 2024 Program (Tentative)
Introduction
History of Heavy Ion Radiotherpy

Hirohiko Tsujii

M.D., Ph.D.

QST

J-CROS

Hitoshi Ishikawa

M.D., Ph.D.

QST

1 Radiobiology of charged particle therapy

Sumitaka Hasegawa

M.D., Ph.D.

QST

2 Biophysics of charged particle therapy

Ryoichi Hirayama

Ph.D.

QST

3 Immunology of photon and charged particle radiotherapy

Tsuguhide Takeshima

Ph.D.

QST

4 Radiation and risk of cancer

Tatsuhiko Imaoka

Ph.D.

QST

5 Immune - CIRT

Hiro Sato

6 Recent basic radiobiological research for CIRTBiologyM.D., Ph.D.

Gunma Univ.

Yukari Yoshida

Ph.D.

Gunma Univ.

1 Accelerator for CIRT

Kota Mizushima

Ph.D.

QST

2 Beam Delivery, QA and Audit

Hideyuki Mizuno

Ph.D.

QST

3 Biological models in CiRTTaku Inaniwa

Ph.D.

QST

4 Treatment planning and range uncertainty in carbon-ion radiotherapy

Nobuyuki Kanematsu

Ph.D.

QST

5 Current status and commissioning of Yonsei CC

Jin Sung Kim

Ph.D.

Yonsei University

6 Image Guided Radio Therapy

Arnold Pompos

Ph.D.

7 Torelance DoseMaria Varnava

Ph.D.

Gunma Univ.

8 Image guidance or ART

Makoto Sakai

Ph.D.

Gunma Univ.

Physics

UT Southwestern MedicalCenter

Clinical
1 GyneKazutoshi Murata M.D., Ph.D.

QST

2 Esophagus

Tetsuro Isozaki

M.D., Ph.D.

QST

3 Eye

Nao Kobayashi

M.D., Ph.D.

QST

4 B&S

Reiko Imai

M.D., Ph.D.

Gunma Univ.

5 Urological

Kana Kobayashi

M.D., Ph.D.

QST

6 Colorectal

Hirotoshi Takiyama M.D., Ph.D.

QST

7 Combined therapy

Masaru Wakatsuki M.D., Ph.D.

QST

8 Pancreas

Makoto Shinoto

M.D., Ph.D.

QST

9 Dose escalation/Multi-ion

Shigeru Yamada

M.D., Ph.D.

QST10 Risk communication

Tomoaki Tamaki

M.D., Ph.D.

11 Facility intro & Cost benefit

Tatsuya Ohno

M.D., Ph.D.

Gunma Univ.

12 LiverKei Shibuya

M.D., Ph.D.

Gunma Univ.

13 Lung

Nobuteru Kubo

M.D., Ph.D.

Gunma Univ.

14 H&N

Atsushi Musha

M.D., Ph.D.

Gunma Univ.

Fukushima MedicalUniversity

Diagnosis
1 The Role of Nuclear Medicine in Cancer Treatment

Miwako Takahashi M.D., Ph.D.

QST

2 Reporting System for MRI Assessment of Prostate Cancer

Riwa Kishimoto

M.D., Ph.D.

QST

3 PET Physics - Current and Future Prospects

Taiga Yamaya

Ph.D.

QSTTopics
1 Overview of BNCT and Current status of Accelerated-based BNCT
2History of particle beam therapy in Japan from the perspective of national
health policy

Yoshihiro Takai

M.D., Ph.D.

Hideyuki Sakurai

M.D., Ph.D.

Southern Tohoku BNCT
Research Center
Tsukuba Univ.

Tour & Case Study
1 Tour (QST)

Yoshiyuki Iwata

QST

2 Tour (OMR)

n. a.

QST

3 Case Study 1 LiverKei Shibuya

M.D., Ph.D.

Gunma Univ.

4 Case Study 2 Lung

Nobuteru Kubo

M.D., Ph.D.

Gunma Univ.

5 Case Study 3 H&N

Atsushi Musha

M.D., Ph.D.

Gunma Univ.

6 Tour (GHMC)

Tatsuya Ohno

M.D., Ph.D.

Gunma Univ.

1 SAGA HIMAT, SAGA Heavy Ion Medical Accelerator in Tosu

Yoshiyuki Shioyama M.D., Ph.D.

Saga-HIMAT

2 East Japan Heavy Ion Center, Faculty of Medicine, Yamagata University

Takeo Iwai

Yamagata Univ.

Facility Introduction
Ph.D. M. P.

Lunch time Seminar / Afternoon Seminar / Vender presentation
1 Anzai Medical co., Ltd.

n. a.

Anzai Medical Co., Ltd.

2 B dot Medical Inc.

n. a.

B dot Medical Inc.

3 Hitachi High-Tech Corporationn. a.

Hitachi High-Tech Corporation

4 RaySearch Japan K.K.

n. a.

RaySearch Japan K.K.

5 Sumitomo Heavy Industries, Ltd.

n. a.

Sumitomo Heavy Industries, Ltd.

6 Toshiba Energy Systems & Solutions Corporationn. a.

7 Cosylab Japan Inc.

n. a.

Cosylab Japan Inc.

8 Alfresa Pharma Corporation

n. a.

Alfresa Pharma Corporation

9 NHa(Normandy Hadrontherapy)

Virgile LetellierNha*) QST : National Institutes for Quantum Science and Technology

Toshiba Energy Systems & Solutions
Corporation